期刊
CHEMISTRY AND PHYSICS OF LIPIDS
卷 200, 期 -, 页码 94-103出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.chemphyslip.2016.08.002
关键词
Cystic fibrosis; Sphingolipids; Lipid rafts; Inflammation
资金
- Italian Cystic Fibrosis Research Foundation (FFC) [24/2014, 22/2015, 9/2015, 18/2009, 19/2011, 17/2014]
Cystic fibrosis (CF), one of the most common lethal hereditary diseases of white European populations, is caused by loss-of-function mutations in the CF Transmembrane conductance Regulator (CFTR) gene. One of the main causes of mortality is the onset of CF lung disease, which is characterized by chronic infection and inflammation resulting in the progressive remodelling, irreversible damage and fibrosis of the airways. An increasing number of studies indicate that sphingolipids are crucial players in pulmonary manifestations of CF, even if their direct involvement in CF lung disease is still unclear. In this review, we give an overview of the role of sphingolipids in CF pulmonary disease, focusing on the relationship between glycosphingolipids and lung inflammation, which represents the main hallmark of this disease. (C) 2016 The Author(s). Published by Elsevier Ireland Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据